Elvisfan schreef op 13 februari 2020 19:33:
[...]
hopelijk wordt het positief Rikske , anders wordt het alweer een ramp aandeel, -30-50% en meer verlies? dit even terzijde
kijk en lees eens volgende link, zeer technisch, jawel
en.wikipedia.org/wiki/Amisulprideeen paragraaf die me toch opvalt :
It was introduced by Sanofi-Aventis in the 1990s. Its patent had expired by 2008 and hence generic formulations are now available.It is marketed in all English-speaking countries except for Canada and the United States. A New York City based company, LB Pharmaceuticals, has announced the development of a version of amisulpride specifically targeting the United States although it is unclear when that product would actually be on the market.A poster presentation at ECNP[clarification needed] seems to suggest that this version of amisulpride, known as LB-102 displays the same binding to D2, D3 and 5HT7 that amisulpride does.